Randomized Controlled Trial Comparing Residual Kidney Function in Patients Undergoing Three or Four Exchanges CAPD
3 other identifiers
interventional
139
1 country
1
Brief Summary
The purpose of this study was to explore the impacts of different continuous ambulatory peritoneal dialysis (CAPD) dosage (three 2-Liter exchanges CAPD vs. four 2-Liter exchanges CAPD) on residual kidney function, technique survival, patient survival, and peritonitis in incident Chinese peritoneal dialysis patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Jun 2004
Longer than P75 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2004
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2010
CompletedFirst Submitted
Initial submission to the registry
July 1, 2012
CompletedFirst Posted
Study publicly available on registry
July 11, 2012
CompletedJuly 22, 2016
July 1, 2016
6.2 years
July 1, 2012
July 20, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Residual kidney function including glomerular filtration rate (GFR), daily urine voume (Uvol), and anuria-free survival.
GFR was calculated by the mean of renal clearance of urea and creatinine from a 24-h urine collection. Anuria was termed as consistently Uvol \< 100 ml/day for more than a month.
Up to 24 months after CAPD initiation
Secondary Outcomes (3)
Number of participants having technique failure refering to switching to maintenance hemodialyisis
Up to 24 months after CAPD initiation.
Number of participants died
Up to 24 months after CAPD initiation
Episodes of peritonitis
Up to 24 months after CAPD initiation
Study Arms (2)
Three 2-liter exchanges group
EXPERIMENTALA group of randomly assigned patients undergoing three 2-liter exchanges daily CAPD.
Four 2-liter exchanges group
ACTIVE COMPARATORA group of randomly assigned patients undergoing four 2-liter exchanges daily CAPD.
Interventions
CAPD regimen of three 2-liter daily exchanges
CAPD regimen of four 2-liter daily exchagnes
Eligibility Criteria
You may qualify if:
- incident CAPD patients aged 18 to 80 years
- GFR ≥ 2 ml/min and Uvol ≥ 500 ml/day
You may not qualify if:
- have a history of maintenance hemodialysis or renal transplantation
- anticipated life expectancy less than 6 months
- with active malignancy, acute infection, significant heart failure or in other severe conditions
- unable to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Renji Hospital, Shanghai Jiao Tong University school of medicine
Shanghai, Shanghai Municipality, 200127, China
Related Publications (4)
Lo WK, Jiang Y, Cheng SW, Cheng IK. Survival of CAPD patients in a center using three two-liter exchanges as standard regime. Perit Dial Int. 1996;16 Suppl 1:S163-6.
PMID: 8728185BACKGROUNDSzeto CC, Lai KN, Yu AW, Leung CB, Ho KK, Mak TW, Li PK, Lam CW. Dialysis adequacy of Asian patients receiving small volume continuous ambulatory peritoneal dialysis. Int J Artif Organs. 1997 Aug;20(8):428-35.
PMID: 9323505BACKGROUNDFang W, Qian J, Lin A, Rowaie F, Ni Z, Yao Q, Bargman JM, Oreopoulos DG. Comparison of peritoneal dialysis practice patterns and outcomes between a Canadian and a Chinese centre. Nephrol Dial Transplant. 2008 Dec;23(12):4021-8. doi: 10.1093/ndt/gfn372. Epub 2008 Sep 12.
PMID: 18790809BACKGROUNDSinghal MK, Bhaskaran S, Vidgen E, Bargman JM, Vas SI, Oreopoulos DG. Rate of decline of residual renal function in patients on continuous peritoneal dialysis and factors affecting it. Perit Dial Int. 2000 Jul-Aug;20(4):429-38.
PMID: 11007375BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wei Fang, MD, PhD
Renal Division, Renji Hospital, Shanghai Jiaotong University School of Medicine
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
July 1, 2012
First Posted
July 11, 2012
Study Start
June 1, 2004
Primary Completion
August 1, 2010
Study Completion
August 1, 2010
Last Updated
July 22, 2016
Record last verified: 2016-07
Data Sharing
- IPD Sharing
- Will not share